Department of Radiation Oncology, St. Luke's International Hospital, Tokyo, Japan.
Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):e117-20. doi: 10.1016/j.ijrobp.2011.11.075. Epub 2012 Feb 28.
To determine the current patterns of practice in Japan and to investigate factors that may make clinicians reluctant to use single-fraction radiotherapy (SF-RT).
Members of the Japanese Radiation Oncology Study Group (JROSG) completed an Internet-based survey and described the radiotherapy dose fractionation they would recommend for four hypothetical cases describing patients with painful bone metastasis (BM). Case 1 described a patient with an uncomplicated painful BM in a non-weight-bearing site from non-small-cell lung cancer. Case 2 investigated whether management for a case of uncomplicated spinal BM would be different from that in Case 1. Case 3 was identical with Case 2 except for the presence of neuropathic pain. Case 4 investigated the prescription for an uncomplicated painful BM secondary to oligometastatic breast cancer. Radiation oncologists who recommended multifraction radiotherapy (MF-RT) for Case 2 were asked to explain why they considered MF-RT superior to SF-RT.
A total of 52 radiation oncologists from 50 institutions (36% of JROSG institutions) responded. In all four cases, the most commonly prescribed regimen was 30 Gy in 10 fractions. SF-RT was recommended by 13% of respondents for Case 1, 6% for Case 2, 0% for Case 3, and 2% for Case 4. For Case 4, 29% of respondents prescribed a high-dose MF-RT regimen (e.g., 50 Gy in 25 fractions). The following factors were most often cited as reasons for preferring MF-RT: "time until first increase in pain" (85%), "incidence of spinal cord compression" (50%), and "incidence of pathologic fractures" (29%).
Japanese radiation oncologists prefer a schedule of 30 Gy in 10 fractions and are less likely to recommend SF-RT. Most Japanese radiation oncologists regard MF-RT as superior to SF-RT, based primarily on the time until first increase in pain.
确定日本目前的实践模式,并调查可能使临床医生不愿意使用单次分割放疗(SF-RT)的因素。
日本放射肿瘤学研究组(JROSG)的成员完成了一项基于互联网的调查,并描述了他们对四个描述患有疼痛性骨转移(BM)患者的假设病例的放疗剂量分割建议。病例 1 描述了一位非小细胞肺癌患者的非承重部位无并发症的疼痛性 BM。病例 2 研究了对无并发症脊柱 BM 的处理是否与病例 1 不同。病例 3 与病例 2 相同,只是存在神经性疼痛。病例 4 研究了多发性转移乳腺癌继发的无并发症疼痛性 BM 的处方。对推荐病例 2 采用多分割放疗(MF-RT)的放射肿瘤学家,要求其解释为何认为 MF-RT 优于 SF-RT。
共有来自 50 个机构(JROSG 机构的 36%)的 52 名放射肿瘤学家做出了回应。在所有四个病例中,最常推荐的方案是 30Gy/10 次。13%的受访者推荐病例 1 采用 SF-RT,6%推荐病例 2,0%推荐病例 3,2%推荐病例 4。对于病例 4,29%的受访者推荐了高剂量 MF-RT 方案(例如 50Gy/25 次)。最常被引用作为偏好 MF-RT 的原因包括:“首次疼痛加重的时间”(85%)、“脊髓压迫的发生率”(50%)和“病理性骨折的发生率”(29%)。
日本放射肿瘤学家更喜欢采用 30Gy/10 次的方案,不太可能推荐 SF-RT。大多数日本放射肿瘤学家认为 MF-RT 优于 SF-RT,主要是基于首次疼痛加重的时间。